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Abstract
Approximately 11% of all new breast cancer cases in the USA occur in women aged 45 years or 
younger. In 2011, CDC funded seven organizations to develop or enhance programs for young 
breast cancer survivors (YBCS). This paper analyzed program evaluation data collected by one of 
these organizations to gain a more nuanced understanding of how recipients used the newly 
developed program and resources for YBCS. Sharsheret’s Thriving Again program was evaluated 
through a web-based survey of survivorship program participants. The evaluation asked questions 
about participant demographics, use of the kit’s survivorship care plan (SCP), satisfaction with the 
timing of survivorship kit receipt, and factors related to survivors’ use of additional Sharsheret 
programs. We conducted bivariate analyses of survey responses and calculated chi-square statistics 
for significance testing. Of the 163 women who responded to the survey, 43% were diagnosed 
with breast cancer at or before age 45 and 69% were of Jewish descent. The majority of women 
who used the SCP found it helpful to facilitate cancer treatment (94%), follow-up (85%), or 
discussions with providers (91%). A total of 75% of women who received the SCP kit while either 
recently diagnosed or undergoing treatment were satisfied with the timing of receipt. Survey 
respondents found the Thriving Again program and survivorship kit beneficial and indicated 
timing preferences for when to receive resources and support. Supporting the self-efficacy of 
cancer survivors may improve survivors’ quality of life and is an important aspect of survivorship 
programs.
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Background
Although most breast cancers occur in women who are 50 and older, approximately 11% of 
all new cases of breast cancer in the USA occur in women younger than 45 years of age [1, 
2]. Although breast cancer diagnosis and treatment may be difficult for women of any age, 
young survivors face unique physical and psychosocial challenges. Young women with 
breast cancer may undergo treatment-induced menopause, which can result in weight gain, 
fatigue, and sleep disturbances, among other physical symptoms [3]. Additionally, breast 
cancers occurring in younger women are typically more aggressive and can result in a worse 
prognosis than breast cancers developing in post-menopausal women [2–5]. Breast cancer at 
an early age often indicates genetic mutations (BRCA1, BRCA2, or TP53) or family history 
of the disease, making these women more susceptible to secondary breast and ovarian cancer 
diagnoses [6]. Women of Ashkenazi Jewish descent are at particular risk of developing 
breast cancer at a younger age because approximately one out of 40 women of this 
population carries a BRCA gene mutation [7].
Psychosocial difficulties young breast cancer survivors (YBCS) often face are related to the 
adolescent and young adult (AYA) paradox which is the “disjuncture between developmental 
experiences and expectations of young adults and the ways in which the cancer experience 
has been implicitly defined or understood in terms of middle and late adulthood” [8]. Such 
developmentally discordant experiences of YBCS include confronting treatment-related 
fertility issues, including premature menopause, feeling out of sync with peers, needing to 
put a career on hold, and undergoing cancer treatment while also caring for young children 
[3, 9–12]. Despite the unique challenges YBCS face, until recently, there had been few 
programs to help these young women deal with these issues [13].
In September 2011, The Centers for Disease Control and Prevention (CDC) awarded 
funding to seven organizations for a new three-year cooperative agreement, “Developing 
Support and Educational Awareness for Young (<45) Breast Cancer Survivors in the United 
States,” as part of a broader effort to support breast cancer awareness in young women [14]. 
This program provided resources to organizations to establish or enhance existing support 
services for YBCS and their families and to develop tools and resources intended to increase 
patient and provider knowledge of health behaviors and other strategies for reducing disease 
risk and improving overall health, wellness, and quality of life [14].
One of the funded programs was Sharsheret®, a national, not-for-profit organization that 
supports young Jewish women and their families facing breast cancer. Founded in 2001, 
Sharsheret offers a community of support to Jewish women diagnosed with breast cancer, or 
at increased genetic risk for developing breast cancer, by offering women culturally relevant 
connections with resources, health professionals, and a network of peers. Although 
Sharsheret focuses on working with Jewish women, they serve any woman with breast 
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cancer (at any point along the cancer survivorship continuum) who contacts them. With the 
CDC funding, Sharsheret developed the Thriving Again® program, consisting primarily of 
customizable survivorship kits. The Thriving Again survivorship kits contain various 
resources for recipients tailored to meet their needs. YBCS can select from a variety of 
printed resources addressing topics such as exercise after treatment, communication with 
family members and friends, smoking cessation, and fear of recurrence. Recipients can also 
select among several cookbooks and fitness DVDs. All kits contain a survivorship care plan 
(SCP) for YBCS to complete with their health-care team, which includes a self-assessment 
of psychosocial concerns that may affect YBCS throughout survivorship. Offering SCPs in 
the kits is consistent with the American College of Surgeons’ Commission on Cancer (CoC) 
requirement that its accredited facilities must provide SCP to at least 75% of survivors 
treated in each of its accredited facilities (to be phased in over a 3-year period) [15]. The 
purpose of this paper is to offer a nuanced understanding of how recipients used components 
of the Thriving Again program, through an evaluation of program participants, placing 
particular emphasis on the survivorship kits and SCP usage. Consideration was also given to 
survivors’ satisfaction with the point along their survivorship journey at which they received 
the Thriving Again survivorship kit.
Methods
Thriving Again Program
Over the course of the 3-year cooperative agreement, Sharsheret distributed a total of 1465 
tailored Thriving Again survivorship kits to women with breast cancer and 187 kits to 
health-care providers for sharing with the YBCS population they serve. In addition to 
receiving the survivorship kit, YBCS were directly linked to two other Sharsheret programs: 
Genetics for Life® and health-care teleconferences. Over the course of the grant period, 380 
guided conversations about genetics took place between callers and the Sharsheret Support 
Team. As part of the Thriving Again program, Sharsheret developed five nationally available 
teleconferences that focused on addressing the concerns of YBCS. Topics included overall 
breast cancer survivorship, managing relationships, genetics, long-term effects of breast 
cancer treatment, and nutrition and exercise for breast cancer survivors. Over the course of 
the grant period, over 600 people participated in the YBCS-focused teleconferences. Audio 
recordings and written transcripts of the teleconferences were posted to the Sharsheret 
website (http://www.sharsheret.org/) for participants to reference later and for new visitors to 
access at their convenience.
Program Evaluation Survey
Evaluation surveys were distributed to recipients to gauge satisfaction with the Thriving 
Again program overall, including linking to other Sharsheret programs, and to improve and 
further refine the survivorship kits. The surveys particularly focused on the use of 
survivorship kit materials and the SCPs included in those kits.
The self-report, web-based survey was developed and conducted by Sharsheret, with limited 
input from CDC. The survey included questions addressing basic demographic information, 
background information about the timing of kit receipt, use of the SCP, the usefulness of the 
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printed resources a survivor selected (and received) as part of her kit, and whether the 
survivor accessed additional Sharsheret programs, i.e., teleconferences and Genetics for 
Life. Questions were primarily closed-ended and several included Likert-type scales.
Breast cancer survivors who contacted Sharsheret and received a Thriving Again 
survivorship kit between September 1, 2012, and April 30, 2014, were invited to complete 
an online or paper survey evaluating Sharsheret’s survivorship support services. The survey 
was sent in two waves. In February 2014, 717 emails were sent electronically to all women 
who received a survivorship kit before January 1, 2014. A total of 85 responses were 
collected during the first wave. In May 2014, 930 emails were sent electronically and 42 
paper surveys (requested by women in lieu of the online survey) were mailed to women who 
received a survivorship kit before April 30, 2014. A total of 78 responses were collected in 
wave 2, resulting in a total survey sample size of 163. Data collection was anonymous, 
although survey links were unique to individuals so Sharsheret could track non-response and 
check for duplicate responses. While women who responded to wave 1 did not receive a 
second email, non-respondents from wave 1 did receive an email in wave 2, resulting in a 
response rate of 16%. While lower than expected, this response rate is not unusual for this 
type of web-based evaluation [16, 17].
Data Analysis
Electronic data files from survey waves 1 and 2 were downloaded from electronic 
submission form, imported into SAS 9.3 (SAS Institute Inc., Cary, NC), and merged 
together to form the analytic dataset.
We included the following demographic variables and clinical characteristics in our analysis: 
current age at time of survey completion, marital status, having any children, census region 
of residence, race/ethnicity, Jewish descent, Jewish identity (Chassidic, Conservative, 
Orthodox, Reform, Spiritual, Traditional, Unaffiliated, Other), education level, stage at 
diagnosis, treatment status, age at breast cancer diagnosis, and identity as a cancer survivor. 
We combined categories for certain variables from their original survey format such as 
current age (21–34, 35–40, 41–45, 46–50, and 51 years and older), marital status (single, 
never married, married, divorced/separated, unmarried, and widowed), age at diagnosis (≤45 
vs. >45 years), Jewish identity (Chassidic/Orthodox vs. other affiliation), treatment status 
(currently in initial treatment or on hormonal therapy vs. not currently in treatment/other), 
identity as a cancer survivor (yes vs. no, I do not consider myself a survivor), and timing of 
receipt of the Thriving Again kit (when first diagnosed or while undergoing treatment for 
breast cancer, while undergoing treatment for metastatic disease, 1–5 years after treatment 
was completed, and more than 5 years after treatment was completed). Outcomes of interest 
included completion and frequency of use of the Thriving Again SCP, factors associated 
with participation in teleconferences and the Genetics for Life program, and satisfaction 
with the timing of receipt of the Thriving Again survivorship kit. For each care plan 
component (tracking treatment and medical information, using it to plan follow-up 
screenings and appointments, using it to guide conversations with a doctor or medical team, 
and using the self-assessment tool), frequency of use was collapsed into two categories: 
often/sometimes vs. never. Women were counted as having participated in the Genetics for 
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Life program if they had spoken with Sharsheret’s certified genetic counselor when they 
ordered their Thriving Again kit (n = 24) or if they indicated on the survey they would like 
to be connected to the genetic counselor (n = 10). Women who did not express interest in 
referral because they had already spoken with a genetic counselor and did not have any 
additional questions or concerns (n = 72) or who did not answer the questions (n = 17) were 
excluded from the analysis of participation in Genetics for Life. All other women who 
answered “no” to both questions on whether they had spoken with Sharsheret’s genetic 
counselor or would like a referral were counted as “no” responses (n = 40). Satisfaction with 
the timing of receipt of the survivorship kit was measured by this question: “How did you 
feel about the timing of receiving your kit? (‘exactly when I needed it’ or ‘would have liked 
to receive it at another time’).” For women who stated they would have liked to receive the 
Thriving Again kit at a different time, a follow-up question was asked when they would have 
preferred to receive the kit (when first diagnosed, while undergoing treatment for breast 
cancer, when treatment was completed, or “other”).
We conducted a descriptive analysis examining demographic and clinical characteristics of 
women receiving Sharsheret services. We examined, in a bivariate analysis, factors 
associated with completing the Thriving Again care plan, participating in teleconferences, 
and using the Genetics for Life program. We assessed women’s current status within the 
cancer care continuum (i.e., whether currently undergoing treatment and length of time as a 
cancer survivor) and how they felt about the timing of receiving the Thriving Again 
survivorship kit (received kit exactly when resources were needed vs. preferred to have 
received the kit at another time point in their survivorship journey) in a bivariate analysis. 
Among women who reported completing the Thriving Again care plan and answered 
questions about its use (n = 66), we assessed which components of the care plan were used. 
All p values were from chi-squared tests with the significance level set at p < 0.05.
Results
Demographic characteristics of the 163 respondents are listed in Table 1. Slightly less than 
half of survey respondents (48%) were under 50 years old when surveyed and were 
diagnosed with breast cancer at or before age 45 (43%). A majority of respondents were 
married (60%), reported being of Jewish descent (69%), and were college graduates or held 
advanced degrees (78%). The majority of women was diagnosed with either stage I (31%) or 
stage II (34%) breast cancer, and nearly half reported being on either hormonal therapy or 
their initial course of treatment (45%). Most women (84%) self-identified as cancer 
survivors.
Of the women who reported either beginning or completing the Thriving Again SCP (n = 
62), most (94%) used it to keep track of medical information and treatments (Table 2). 
Women also used the care plan to guide conversations with medical professionals (91%) and 
to plan follow-up appointments and screenings (85%). Finally, many women (89%) used the 
care plan’s self-assessment to help them determine what additional resources or support they 
needed.
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Seventy-five percent of women who received the Thriving Again kit while either recently 
diagnosed with breast cancer or undergoing treatment reported receiving the kit “exactly 
when [they] needed it,” compared with 28% of women who received the kit longer than 5 
years after completing treatment (Table 3). Additionally, 62% of women who received the 
kit 1–5 years after completing treatment indicated they received the kit exactly when they 
needed it, while 38% of those women reported they would have preferred receiving the kit at 
another time, specifically, either when first diagnosed or during treatment (71% of the 29) 
(data not shown).
Overall, 47% of women either initiated or completed the Thriving Again SCP, over one third 
participated in a teleconference, and 46% of eligible women participated in Genetics for Life 
(Table 4). Women who participated in the Genetics for Life® program more frequently 
reported having spoken with one of Sharsheret’s clinical team members beforehand, 
compared with women who did not use Genetics for Life (77 vs. 50%; p < 0.05). However, 
contact with Sharsheret’s clinical team members was not associated with either completing 
the SCP or participating in teleconferences. Neither demographic factors nor the timing of 
receipt of the Thriving Again kit was associated with teleconference participation, 
completion of the SCP, or use of Genetics for Life.
Discussion
Our analyses of the Sharsheret evaluation ascertained that survey respondents found the 
Thriving Again program and survivorship kit beneficial, particularly the SCPs. Respondents 
also indicated preferring to receive resources and support early in their survivorship journey, 
as opposed to 5 or more years after treatment completion.
The breast cancer survivors in this evaluation who reported using their SCPs 
overwhelmingly used them in ways outlined by the National Academies’ Health and 
Medicine Division (formerly the Institute of Medicine) [18], i.e., to keep track of medical 
and treatment information, to guide discussions with their health-care professionals, and to 
plan future care. Survivorship care planning, including the development of SCPs themselves, 
has long been identified as being an important component of patient-centered care [19–21]. 
Outcomes research on SCPs is limited. A recent systematic review of qualitative studies of 
the experience of cancer survivors using SCPs found support for the use of care plans, but a 
lack of consensus on care plan format, content, and development (who should be responsible 
for creating the plan) [22]. Our results, which indicate that breast cancer survivors used the 
SCPs primarily as a tool to help them remember their medical information and to help guide 
conversations with their providers, are consistent with Earle and Ganz’s view that, in 
survivorship care planning, providers should “not let the perfect be the enemy of the good” 
[23]. The SCPs in this kit were intended to function as part of a larger survivorship care 
planning effort, specifically to stimulate greater communication between cancer survivors 
and their health-care providers about long-term care and concerns [19, 20, 24]. The 
successful use of the SCPs in these kits demonstrates their value as a means to an end, rather 
than an end in itself.
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The breast cancer survivors’ satisfaction with the timing of receipt of the Thriving Again 
survivorship kit is notable. Since most women in this evaluation who received the kit either 
when first diagnosed or while undergoing treatment (for stage I–III breast cancer) felt they 
had received it when they needed it, this speaks to the desire for survivors to obtain personal, 
age-specific resources and information on follow-up care [25]. This finding may extend to 
the care plan itself. One recent systematic review concluded that cancer survivors prefer to 
have care plans completed by 6 months post-treatment, while also expressing interest in 
having the plan include healthy living recommendations, psychosocial and spiritual 
concerns, signs and symptoms of recurrence, late and long-term effects of treatment, follow-
up recommendations, and a treatment summary [26]. In our evaluation, those who received 
the kit between 1 and 5 years after treatment were also satisfied with the timing, although 
slightly less so. Taken together, these findings may indicate a desire to have access to 
resources early in the disease trajectory to maximize self-efficacy, a major theme among 
young adult cancer survivors [12]. Research on breast cancer survivors has shown that self-
efficacy is enhanced when psychosocial care, including support provided by the Thriving 
Again program, is customized to focus on survivors’ needs throughout the cancer 
survivorship continuum [27].
Strengths and Limitations
One strength of this evaluation is its unique focus on young, Jewish women with breast 
cancer. This is an important population to focus on, since, as previously noted, women of 
Ashkenazi Jewish descent have a higher risk of developing breast cancer at a younger age 
higher than women of other ethnic groups [7]. Another strength of this evaluation is in its 
focus on survivors’ satisfaction with the timing of receiving resources, including SCPs, since 
utility to survivors must be kept in the forefront of the survivorship care planning process 
[23, 24].
This evaluation also has several limitations. First, the evaluation was web-only, that is, it did 
not include follow-up by other media (e.g., paper survey, telephone, and text messages), and 
had a low response rate (16%). As previously noted, however, response rates for web-only 
surveys vary widely [28–30], and rates of under 20% are not unusual [16, 17]. Furthermore, 
the response rate may have been vulnerable to selection bias. The cross-sectional nature of 
the evaluation may also be considered a limitation, since some women surveyed had not yet 
used all of the Thriving Again resources, particularly the SCP. Additionally, the evaluation 
design did not include a comparison group of women who did not receive Thriving Again 
materials or who received other materials. Limitations also included the small sample size, 
which hindered our ability to conduct age-specific analyses and comparisons. Related to 
this, we were unable to fully assess YBCS in this evaluation, given that less than half of 
survey respondents were 45 years of age or younger. While the intended audience of 
Thriving Again is YBCS, the program sent survivorship kits to all women who asked for 
one. Therefore, women of different age groups responded to the survey.
Since YBCS face a unique set of challenges, they also must receive a unique constellation of 
survivorship support services. YBCS, as well as other cancer survivors, may want to have 
control over the types of survivorship information they receive and when they receive it. 
Rohan et al. Page 7













Survivorship programs foster self-efficacy when they not only encourage survivors to tailor 
their own survivorship materials from a broad selection of relevant resources but also 
consider the timing of providing particular resources to survivors. Findings from this 
evaluation may be helpful to other survivorship programs for YBCS. Most notably, other 
programs may need to be aware of how patients use SCPs and when survivors feel they most 
need resources and support.
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Table 1
Demographic and other characteristics of breast cancer survivors responding to Sharsheret Thriving Again 
survey (n = 163)
Characteristic n (%)
Current age, years
 21–34 10 (7.2)
 35–40 11 (7.9)
 41–45 19 (13.7)
 46–50 26 (18.7)
 51 and older 73 (52.5)
Age at diagnosis, years
 ≤45 57 (42.9)
 >45 and older 76 (57.1)
Marital status
 Married 83 (60.1)
 Single, never married 22 (15.9)
 Divorced/separated 26 (18.8)
 Unmarried (LGBT) 4 (2.9)
 Widowed 3 (2.2)
Census region of residence
 Northeast 58 (46.4)
 Midwest 10 (8.0)
 South 35 (28.0)
 West 22 (17.6)
Race/ethnicity
 Black or African American 12 (8.8)
 Caucasian 119 (86.9)
 Hispanic/Latina 3 (2.2)
 Other 3 (2.2)
Of Jewish descent 96 (69.1)
Jewish identity
 Orthodox/Chassidic 36 (38.3)
 Other affiliation 58 (61.7)
Education level
 Advanced/professional degree 58 (42.0)
 College graduate 50 (36.2)
 High school graduate 7 (5.1)
 Some college or technical school 21 (15.2)
 Some high school (9–12) 2 (1.5)
Stage
 DCIS 16 (12.7)
 Stage I 39 (31.0)
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Characteristic n (%)
 Stage II 43 (34.1)
 Stage III 17 (13.5)
 Stage IV 11 (8.7)
Treatment status
 Currently in initial treatment or on hormonal therapy 62 (44.6)
 Not currently in treatment/other 77 (55.4)
Had children at time of diagnosis 100 (71.9)
Identify as cancer survivor 106 (84.1)
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Table 2
Recipients’ use of the Thriving Again care plan (n = 66)a
I use care plan to Often/sometimes n (%) Never n (%)
Keep track of medical information/treatments* 62 (93.9) 4 (6.1)
Help plan follow-up appointments/screenings* 56 (84.9) 10 (15.2)
Help guide conversations with doctor* 60 (90.9) 6 (9.1)
Gauge issues struggling with and determine 
additional resources/support needed through the 
self-assessment*
59 (89.4) 7 (10.6)
Is there anything else you would care to share about 
the care plan?
Illustrative quote “It was the perfect motivational tool to get 
all of my stacks of cancer information, tests, 
scans and other medical records organized 
and [usable].”
“Would have been very helpful to have 
when I first completed treatment. [I] 
would probably still be using it, but 
now it’s hard to start, since haven’t 
been using it from the beginning.”
*
p < 0.05 from chi-squared tests of equal proportions
a
This analysis was limited to women who indicated that they either began or completed their care plan and answered questions on how they used 
their kit (n = 66)
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Table 3
Timing of receipt of Thriving Again survivorship kit (n = 163)
Timing of kit receipt* Received kit when needed
it (n = 99)
n, (row %, column %)
Preferred another time
(n = 64)
n, (row %, column %)
When first diagnosed or while undergoing treatment for breast cancer 36 (75.0, 36.4) 12 (25.0, 18.8)
While undergoing treatment for metastatic disease 8 (80.0, 8.1) 2 (20.0, 3.1)
1–5 years after treatment completed 47 (61.8, 47.5) 29 (38.2, 45.3)
More than 5 years after treatment completed 8 (27.6, 8.1) 21 (72.4, 32.8)
*
Statistically significant, p < 0.05 from chi-squared test
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